Veteran investor with experience across buyouts, growth equity and operational turnarounds, focusing on technology and healthcare sectors. Richard Harris brings senior leadership in deal sourcing, portfolio company governance and capital markets engagement, often leading value-creation programs and follow-on financings. Active on corporate boards, known for driving strategic repositioning and exit preparation. Relevant to LPs and advisors evaluating mid-market private equity allocations and management teams.
Veteran investor with experience across buyouts, growth equity and operational turnarounds, focusing on technology and healthcare sectors. Richard Harris brings senior leadership in deal sourcing, portfolio company governance and capital markets engagement, often leading value-creation programs and follow-on financings. Active on corporate boards, known for driving strategic repositioning and exit preparation. Relevant to LPs and advisors evaluating mid-market private equity allocations and management teams.
Combines buyout rigor with growth-equity flexibility, prioritizing control or influential minority positions in mid-market technology and healthcare companies where operational improvements unlock value. Emphasizes thesis-driven deal sourcing, hands-on governance, and staged capital deployment tied to measurable KPIs. Favors repeatable value-creation playbooks—product strategy, commercial scale-up, and margin expansion—while maintaining disciplined exit timing through active board oversight and capital markets readiness to optimize IRR and downside protection.
Combines buyout rigor with growth-equity flexibility, prioritizing control or influential minority positions in mid-market technology and healthcare companies where operational improvements unlock value. Emphasizes thesis-driven deal sourcing, hands-on governance, and staged capital deployment tied to measurable KPIs. Favors repeatable value-creation playbooks—product strategy, commercial scale-up, and margin expansion—while maintaining disciplined exit timing through active board oversight and capital markets readiness to optimize IRR and downside protection.
| Trades 772 | Longs Won 562/772 72% | Profit Factor 14.7 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $221,696.89 |
| Average Win $74,595.49 | Best Trade (Aug 14) $3.25M | Sharpe Ratio -13.27 |
| Average Loss -$13,582.08 | Worst Trade (Mar 30) -$532,539.18 | Z-Score 17.9 (100%) |
| Commissions $0 | Avg. Trade Length 10m 2w 5d | Expectancy $50,609.36 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 12,987 | 11,688 | 10,390 | 9,091 | 7,792 | 6,494 | 5,195 | 3,896 | 2,597 | 1,299 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 40,583 | $9.98M | $12.54M | - | $2.55M | 25.56% | -7.354% |
ABBV AbbVie Inc. | 2,599 | $464,192.39 | $652,193.06 | - | $188,000.67 | 40.5% | -2.513% |
ADI Analog Devices, Inc. | 3,061 | $659,486.71 | $1.12M | - | $465,155.3 | 70.53% | +0.202% |
AKRE Akre Focus ETF | 5,467 | $358,143 | $314,297.83 | - | -$43,845.17 | -12.24% | -0.087% |
ALL Allstate Corporation | 2,250 | $434,891.09 | $594,179.97 | - | $159,288.88 | 36.63% | -0.49% |
AMD Advanced Micro Devices, Inc. | 2,973 | $411,657.64 | $1.42M | - | $1M | 243.88% | -1.904% |
AMZN Amazon.com Inc | 13,308 | $2.93M | $3.61M | - | $681,569.76 | 23.24% | +15.321% |
APD Air Products and Chemicals, Inc. | 2,158 | $626,297.71 | $636,372.64 | - | $10,074.93 | 1.61% | -1.769% |
AVGO Broadcom Inc. | 2,734 | $641,059.93 | $1.06M | - | $423,231.59 | 66.02% | +0.371% |
BA Boeing Company | 1,166 | $206,316.01 | $252,019.24 | - | $45,703.23 | 22.15% | -2.155% |
BP BP p.l.c. Sponsored ADR | 7,251 | $246,054.87 | $327,890.22 | - | $81,835.35 | 33.26% | +2.261% |
BRK-B Berkshire Hathaway Inc. | 2,233 | $1.01M | $1.14M | - | $130,094.96 | 12.85% | +0.365% |
CAT Caterpillar Inc. | 1,079 | $393,830.13 | $879,179.99 | - | $485,349.86 | 123.24% | +0.701% |
CB Chubb Limited | 1,589 | $461,433.48 | $557,230.5 | - | $95,797.02 | 20.76% | +0.151% |
CGBL Capital Group Core Balanced ETF | 6,531 | $247,921 | $243,149.13 | - | -$4,771.87 | -1.92% | -0.054% |
CGCB Capital Group Core Bond ETF | 25,070 | $657,452.3 | $645,552.5 | - | -$11,899.8 | -1.81% | -0.656% |
CGCP Capital Group Core Plus Income ETF | 47,454 | $1.07M | $1.04M | - | -$29,656.86 | -2.77% | -0.68% |
CGCV Capital Group Conservative Equity ETF | 15,653 | $492,124.85 | $518,270.83 | - | $26,145.98 | 5.31% | -0.06% |
CGDG Capital Group Dividend Growers ETF | 39,349 | $1.29M | $1.51M | - | $215,807.55 | 16.69% | -0.234% |
CGDV Capital Group Dividend Value ETF | 125,705 | $4.75M | $6.23M | - | $1.48M | 31.13% | +0.63% |